Therapeutic Uses
Anti-Thrombotics
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
N1-(5-chloropyridin-2-yl)-N2-((1R,2S,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Ent-Edoxaban is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Ent-Edoxaban usage and description
Ent-Edoxaban is a medication that is primarily used to prevent blood clots in individuals who have had recent knee or hip replacement surgery. This medication belongs to a class of drugs known as factor Xa inhibitors, which work by blocking the action of a protein called factor Xa that is responsible for the formation of blood clots. By doing so, Ent-Edoxaban reduces the risk of developing blood clots that can lead to serious health problems such as stroke or pulmonary embolism.
Chemically, Ent-Edoxaban is a selective inhibitor of factor Xa that is derived from the parent compound edoxaban. It has a molecular weight of 417.5 g/mol and a chemical formula of C24H30ClN7O4S. This medication is available in the form of tablets that are taken orally, typically once a day. The recommended dosage of Ent-Edoxaban may vary depending on individual factors such as age, weight, and medical history.
While Ent-Edoxaban is generally well-tolerated, it may cause side effects such as bleeding, bruising, or gastrointestinal discomfort. As with any medication, it is important to use Ent-Edoxaban only as directed by a healthcare provider and to monitor for any adverse reactions. Individuals taking Ent-Edoxaban should also avoid taking other medications that may increase the risk of bleeding, such as aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs).
